Session

Prostate cancer: Outcomes after radiotherapy and brachytherapy

Poster Session 61

  • Location:
    Room Milan, North Hall (Level 1)
  • Chairs:
     A. Bossi, Villejuif (FR)
     W.C. Loidl, Linz (AT)
     C. Surcel, Bucharest (RO)
  • Aims and objectives of this session

    To evaluate radiotherapy and brachytherapy protocols and oncological and functional results.

  • Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion. Extended presentations (*) are 3 minutes in length, followed by 3 minutes for discussion.
805
Optimization of assessment tool for lower urinary symptom flare in patients with localized prostate cancer treated with iodine-125 implant brachytherapy

By: Miyake M.1, Tanaka N.1, Asakawa I.2, Hori S.1, Morizawa Y.1, Tatsumi Y.1, Nakai Y.1, Anai S.1, Hasegawa M.2, Konishi N.3, Fujimoto K.1

Institutes: 1Nara Medical University, Dept. of Urology, Nara, Japan, 2Nara Medical University, Dept. of Radiation Oncology, Nara, Japan, 3Nara Medical University, Dept. of Pathology, Nara, Japan

806
Impact of ISUP new grading system on prognostic prediction in clinical stage T3 prostate cancer undergoing high-dose-rate brachytherapy

By: Tsumura H.1, Satoh T.1, Tabata K-I.1, Ishiyama H.2, Ikeda M.1, Kurosaka S.1, Fujita T.1, Hayakawa K.1, Iwamura M.1

Institutes: 1Kitasato University School of Medicine, Dept. of Urology, Sagamihara, Japan, 2Kitasato University School of Medicine, Dept. of Radiology and Radiation Oncology, Sagamihara, Japan

807
Ten year outcomes of real time “4D” brachytherapy in prostates up to 100cc

By: Rea A.1, Rogers P.2, Jones A.1

Institutes: 1Royal Berkshire Hospital, Dept. of Urology, Reading, United Kingdom, 2Royal Berkshire Hospital, Dept. of Oncology, Reading, United Kingdom

808
Long-term outcomes of permanent prostate brachytherapy

By: Stone N.1, Stock R.2

Institutes: 1The Icahn School Of Medicine At Mount Sinai, Dept. of Urology, New York, United States of America, 2The Icahn School Of Medicine At Mount Sinai, Dept. of Radiation Oncology, New York, United States of America

809
Outcomes of treatment for localized prostate cancer in a single institution; comparison of radical prostatectomy vs radiation therapy -Propensity Score Matching Analysis-

By: Hayashi N.1, Yokomizo Y.1, Kimito O.1, Makiyama K.1, Kondo K.1, Nakaigawa N.1, Yao M.1, Taguri M.2, Sugiura M.3, Ito E.3, Takano S.3, Mukai A.3

Institutes: 1Yokohama City University School of Medicine, Dept. of Urology, Yokohama, Japan, 2Yokohama City University School of Medicine, Dept. of Biostatistics, Yokohama, Japan, 3Yokohama City University School of Medicine, Dept. of Radiology, Yokohama, Japan

810
Oncological outcomes of prostate cancer treated by radical prostatectomy versus radiotherapy: A multi-center study using propensity-matched and competing risk regression analyses

By: Koo K.C.1, Lee W.K.6, Kim J.C.1, Bang W.J.2, Lee S.H.3, Cho S.Y.4, Kim S.I.5, Kim S.J.5, Cho J.S.2, Rha K.H.1, Hong S.J.1, Chung B.H.1

Institutes: 1Yonsei University College of Medicine, Gangnam Severance Hospital, Dept. of Urology, Seoul, South Korea, 2Hallym University College of Medicine, Dept. of Urology, Chuncheon, South Korea, 3Yonsei University College of Medicine, Shinchon Severance Hospital, Dept. of Urology, Seoul, South Korea, 4Inje University College of Medicine, Dept. of Urology, Busan, South Korea, 5Ajou University College of Medicine, Dept. of Urology, Suwon, South Korea, 6Hallym University Chuncheon Sacred Heart Hospital, Hallym University College of Medicine, Dept. of Urology, Chuncheon, South Korea

811
The hybrid method can cover an extensive area of planning target volume compared with the conventional method in prostate cancer patients who undergo low-dose-rate brachytherapy

By: Tanaka N.1, Asakawa I.2, Nakai Y.1, Miyake M.1, Anai S.1, Fujii T.3, Hasegawa M.2, Konishi N.3, Fujimoto K.1

Institutes: 1Nara Medical University, Dept. of Urology, Kashihara, Japan, 2Nara Medical University, Dept. of Radiation Oncology, Kashihara, Japan, 3Nara Medical University, Dept. of Pathology, Kashihara, Japan

812
Combined androgen deprivation and radiation versus either modality alone or observation after radical prostatectomy in patients with pathologic node-positive prostate cancer: Analysis of a national hospital cancer registry database

By: Zareba P., Eastham J., Scardino P., Touijer K.

Institutes: Memorial Sloan Kettering Cancer Center, Dept. of Surgery and Urology, New York, United States of America

813
What is the impact of diabetes mellitus on radiation induced proctitis after radical radiotherapy for adenocarcinoma prostate?

By: Paterson C.1, Alashkham A.4, Hubbard S.2, Nabi G.3

Institutes: 1Ninewells Hospital, Dept. of Urology, Dundee, United Kingdom, 2University of Dundee, School of The Environment, Dundee, United Kingdom, 3University of Dundee, Dept. of Urology, Dundee, United Kingdom, 4University of Edinburgh, Centre for Human Anatomy, Edinburgh, United Kingdom

814
Nationwide multicenter retrospective study on high-dose-rate brachytherapy as monotherapy for prostate cancer

By: Komiya A.1, Yoshioka Y.2, Kotsuma T.3, Kariya M.4, Konishi K.5, Nonomura N.6, Fujiuchi Y.7, Kitamura H.7

Institutes: 1Chiba University Graduate School of Medicine, Dept. of Urology, Chiba, Japan, 2Osaka University Graduate School of Medicine, Dept. of Radiation Oncology, Osaka, Japan, 3Osaka National Hospital, Dept. of Radiation Oncology, Osaka, Japan, 4Kochi University Graduate School of Medicine, Dept. of Radiation Oncology, Osaka, Japan, 5Osaka Medical Center for Cancer and Cardiovascular Diseases, Dept. of Radiation Oncology, Osaka, Japan, 6Osaka University Graduate School of Medicine, Dept. of Urology, Osaka, Japan, 7Graduate School of Medicine and Pharmaceutical Sciences For Research, University of Toyama, Dept. of Urology, Toyama, Japan

815
Ex vivo γH2AX assay in prostate cancer patient-derived tumour samples reveals substantial differences in intrinsic radiation sensitivity

By: Neumann E.1, De Colle C.2, Müller A-C.2, Yaromina A.3, Hennenlotter J.1, Stenzl A.1, Scharpf M.4, Fend F.4, Ricardi U.5, Baumann M.6, Zips D.2, Menegakis A.2

Institutes: 1Eberhard Karls University Tübingen, Dept. of Urology, Tübingen, Germany, 2Eberhard Karls University Tübingen, Dept. of Radiooncology, Tübingen, Germany, 3Maastricht University Medical Centre, Dept. of Radiation Oncology, Maastricht, The Netherlands, 4Eberhard Karls University Tübingen, Dept. of Pathology, Tübingen, Germany, 5University of Turin, Dept. of Radiation Oncology (Maastro), Turin, Italy, 6Faculty of Medicine and University Hospital Carl Gustav Carus, Dept. of Radiation Oncology, Dresden, Germany

* 816
Pre-radiotherapy, (robot-assisted) laparoscopic sentinel node dissection and its impact on recurrence and progression of prostate cancer

By: Grivas N.1, Wit E.1, Pos F.2, De Jong J.3, Vegt E.4, Bex A.1, Hendricksen K.1, Horenblas S.1, KleinJan G.5, Van Rhijn B.1, Van Der Poel H.1

Institutes: 1Netherlands Cancer Institute, Dept. of Urology, Amsterdam, The Netherlands, 2Netherlands Cancer Institute, Dept. of Radiation Oncology, Amsterdam, The Netherlands, 3Netherlands Cancer Institute, Dept. of Pathology, Amsterdam, The Netherlands, 4Netherlands Cancer Institute, Dept. of Nuclear Medicine, Amsterdam, The Netherlands, 5Leiden University Medical Center, Dept. of Radiology, Leiden, The Netherlands

Current technique on radiation therapy
 A. Bossi, Villejuif (FR)